Pharsight

1. List of Complera drug patents

Application	Filing Date	Opposition Party	Legal Status
EP04787096A	2016-01-22	Page White & Farrer Limited	Patent maintained as amended
EP11791161A	2015-06-10	HGF Limited	Patent maintained as amended
EP11791161A	2015-06-09	LEK Pharmaceuticals d.d.	Patent maintained as amended
EP05108086A	2012-02-09	Hamm, Volker	The patent has been limited
EP04701819A	2009-03-18	Generics [UK] Limited	Revoked
EP04701819A	2009-03-13	Teva Pharmaceutical Industries LTD.	Revoked

Patent Number	Company	Patent Title	Patent Expiry
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8080551	GILEAD SCIENCES INC	HIV inhibiting pyrimidines derivatives	Apr, 2023 (8 days from now)
US7125879	GILEAD SCIENCES INC	HIV inhibiting pyrimidines derivatives	Apr, 2025 (2 years from now)
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8101629	GILEAD SCIENCES INC	Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile	Aug, 2022 (7 months ago)
US8716264	GILEAD SCIENCES INC	Compositions and methods for combination antiviral therapy	Jan, 2024 (9 months from now)
US9744181	GILEAD SCIENCES INC	Compositions and methods for combination antiviral therapy	Jan, 2024 (9 months from now)
US8592397	GILEAD SCIENCES INC	Compositions and methods for combination antiviral therapy	Jan, 2024 (9 months from now)
US9457036	GILEAD SCIENCES INC	Compositions and methods for combination antiviral therapy	Jan, 2024 (9 months from now)
US8841310	GILEAD SCIENCES INC	Combinations of a pyrimidine containing NNRTI with RT inhibitors	Dec, 2025 (2 years from now)
US10857102	GILEAD SCIENCES INC	Therapeutic compositions comprising rilpivirine HCL and tenofovir disoproxil fumarate	Jan, 2033 (9 years from now)